Press Release
Benaroya Research Institute Welcomes Three New Board Members
Read MoreNews
Immunotherapy Research is Rebooting Seattle's Biotech Sector
Read MoreNews
Developing Disease-Modifying Therapies for Children with Type 1 Diabetes
Read MoreNews
One in Every Three People with Type 1 Diabetes Produces Insulin Years Post-Diagnosis
Read MoreNews
Learn about Immunotherapy and BRI's Work in Seattle Business Magazine
Read MoreNews
Food Allergy Development Linked to Skin Exposure - New Study from Steven Ziegler, PhD
Read MoreNews
BRI to Unravel Insulin Mystery in Type 1 Diabetes: $1.4 Million Grant from JDRF to Understand Critical Question
Read MorePress Release
Benaroya Research Institute to Unravel Insulin Mystery in Type 1 Diabetes: $1.4 Million Grant from JDRF to Understand Critical Question
Read MoreNews
BRI Receives $2.2 Million to Discover Biomarker that Triggers Allergies
Read MorePress Release
Benaroya Research Institute Receives $2.2 Million to Discover Biomarker That Triggers Allergies
Read MoreNews
Accelerator Corporation Secures $51.1 Million to Support Research
Read MorePress Release
Immune Tolerance Network’s TrialShare Recognized for Using Data for Public Good
Read MorePress Release
Benaroya Research Institute Scientists Identify Drivers of Rheumatoid Arthritis
Read MoreNews
Food Allergy Consortium (SeaFAC) to Bring New Research to the Northwest
Read MorePress Release